The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Flolan 1.5 mg powder and solvent for solution for infusion

GlaxoSmithKline (Ireland) LimitedPA1077/058/001

Main Information

Trade NameFlolan 1.5 mg powder and solvent for solution for infusion
Active SubstancesEpoprostenol
Dosage FormPowder and solvent for solution for infusion
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/058/001

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC09 epoprostenol


License statusAuthorised
Licence Issued20/12/2000
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back